Literature DB >> 112622

Effects of chronic d-amphetamine treatment on schedule-controlled behavior.

R A Harris, D Snell, H H Loh.   

Abstract

The effect of d-amphetamine added to the drinking water on the rate of conditioned lever pressing by rats was determined using fixed-ratio 30 (FR-30) and fixed-interval 2-min (FI-2) schedules of food presentation. After 32 days of gradual increase in drug concentration the average drug ingestion was 13 mg/kg/day. In tests with various doses of d-amphetamine injected before and after the chronic ingestion regimen, the rate-decreasing effects of d-amphetamine on FR responding were attenuated after chronic treatment, indicating development of a two- to three-fold tolerance. However, the rate-decreasing effect of d-amphetamine on FI responding was not altered by chronic ingestion. Since acute amphetamine treatment reduced the reinforcement frequency under the FR but not the FI schedule, these results are consistent with the hypothesis that a 'behavioral tolerance' will develop most readily to drug effects that decrease the frequency of reinforcement. Upon removal of d-amphetamine from the drinking water there was some increase in the rate of FR responding, but no change in FI responding.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 112622     DOI: 10.1007/bf00426922

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

Review 1.  Amphetamine toxicity: behavioral and neuropathological indexes.

Authors:  C R Schuster; M W Fischman
Journal:  Fed Proc       Date:  1975-08

2.  Timing behavior during prolonged treatment with dl-amphetamine.

Authors:  C R SCHUSTER; J ZIMMERMAN
Journal:  J Exp Anal Behav       Date:  1961-10       Impact factor: 2.468

3.  Tolerance of rats toward amphetamine and methamphetamine.

Authors:  J W E HARRISSON; C M AMBRUS; J L AMBRUS
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1952-10

Review 4.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

5.  The effects of chronic treatment with d-amphetamine on food intake, body weight, locomotor activity and subcellular distribution of the drug in rat brain.

Authors:  S Magour; H Coper; C Fähndrich
Journal:  Psychopharmacologia       Date:  1974-01-09

6.  Similarities and differences between mescaline, lysergic acid diethylamide-25 (LSD) and d-amphetamine on various components of fixed interval responding in the rat.

Authors:  H A Tilson; S B Sparber
Journal:  J Pharmacol Exp Ther       Date:  1973-02       Impact factor: 4.030

7.  Development of morphine dependence in rats: lack of effect of previous ingestion of other drugs.

Authors:  I P Stolerman; R Kumar; H Steinberg
Journal:  Psychopharmacologia       Date:  1971

8.  Effects of d-amphetamine on performance under several parameters of multiple fixed-ratio, fixed-interval schedules.

Authors:  D E McMillan
Journal:  J Pharmacol Exp Ther       Date:  1969-05       Impact factor: 4.030

9.  The effect of chronic self-administration of d-amphetamine on food intake, locomotor activity, and C14-leucine incorporation into cerebral cortex protein.

Authors:  S Magour; H Coper; C H Fähndrich
Journal:  Psychopharmacologia       Date:  1976-02-02

10.  The duration of tolerance to the anorexigenic effect of amphetamine in rats.

Authors:  K G Götestam; T Lewander
Journal:  Psychopharmacologia       Date:  1975-04-30
View more
  2 in total

Review 1.  Behavioural tolerance to amphetamine and other psychostimulants: the case for considering behavioural mechanisms.

Authors:  C Demellweek; A J Goudie
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

2.  Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.

Authors:  D Snell; R A Harris
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.